Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders

被引:1350
作者
Caughey, B [1 ]
Lansbury, PT
机构
[1] NIAID, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02139 USA
[3] Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02139 USA
关键词
Alzheimer's; Parkinson's; scrapie; prion; amyloid;
D O I
10.1146/annurev.neuro.26.010302.081142
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Many neurodegenerative diseases, including Alzheimer's and Parkinson's and the transmissible spongiform encephalopathies (prion diseases), are characterized at autopsy by neuronal loss and protein aggregates that are typically fibrillar. A convergence of evidence strongly suggests that protein aggregation is neurotoxic and not a product of cell death. However, the identity of the neurotoxic aggregate and the mechanism by which it disables and eventually kills a neuron are unknown. Both biophysical studies aimed at elucidating the precise mechanism of in vitro aggregation and animal modeling studies support the emerging notion that an ordered prefibrillar oligomer, or protofibril, may be responsible for cell death and that the fibrillar form that is typically observed at autopsy may actually be neuroprotective. A subpopulation of protofibrils may function as pathogenic amyloid pores. An analogous mechanism may explain the neurotoxicity of the prion protein; recent data demonstrates that the disease-associated, infectious form of the prion protein differs from the neurotoxic species. This review focuses on recent experimental studies aimed at identification and characterization of the neurotoxic protein aggregates.
引用
收藏
页码:267 / 298
页数:36
相关论文
共 201 条
[1]  
Al-Chalabi Ammar, 2000, Current Opinion in Neurology, V13, P397, DOI 10.1097/00019052-200008000-00006
[2]   AMYOTROPHIC-LATERAL-SCLEROSIS ASSOCIATED WITH HOMOZYGOSITY FOR AN ASP90ALA MUTATION IN CUZN-SUPEROXIDE DISMUTASE [J].
ANDERSEN, PM ;
NILSSON, P ;
ALAHURULA, V ;
KERANEN, ML ;
TARVAINEN, I ;
HALTIA, T ;
NILSSON, L ;
BINZER, M ;
FORSGREN, L ;
MARKLUND, SL .
NATURE GENETICS, 1995, 10 (01) :61-66
[3]   Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia [J].
Andersen, PM ;
Nilsson, P ;
Keranen, ML ;
Forsgren, L ;
Hagglund, J ;
Karlsborg, M ;
Ronnevi, LO ;
Gredal, O ;
Marklund, SL .
BRAIN, 1997, 120 :1723-1737
[4]   GIANT MULTILEVEL CATION CHANNELS FORMED BY ALZHEIMER-DISEASE AMYLOID BETA-PROTEIN [A-BETA-P-(1-40)] IN BILAYER-MEMBRANES [J].
ARISPE, N ;
POLLARD, HB ;
ROJAS, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (22) :10573-10577
[5]   Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AβP (1-40) and (1-42) peptides [J].
Arispe, N ;
Doh, M .
FASEB JOURNAL, 2002, 16 (12) :1526-1536
[6]   Zn2+ interaction with Alzheimer amyloid beta protein calcium channels [J].
Arispe, N ;
Pollard, HB ;
Rojas, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) :1710-1715
[7]   Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease [J].
Auluck, PK ;
Chan, HYE ;
Trojanowski, JQ ;
Lee, VMY ;
Bonini, NM .
SCIENCE, 2002, 295 (5556) :865-868
[8]  
Baldwin MA, 2001, ADV PROTEIN CHEM, V57, P29
[9]   Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrPSc) into contiguous membranes [J].
Baron, GS ;
Wehrly, K ;
Dorward, DW ;
Chesebro, B ;
Caughey, B .
EMBO JOURNAL, 2002, 21 (05) :1031-1040
[10]   Pathway complexity of prion protein assembly into amyloid [J].
Baskakov, IV ;
Legname, G ;
Baldwin, MA ;
Prusiner, SB ;
Cohen, FE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :21140-21148